Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.
about
DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFFImpaired IgA class switching in APRIL-deficient miceAtacicept: targeting B cells in multiple sclerosisThe current status of targeting BAFF/BLyS for autoimmune diseasesB-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related CachexiaThe rationale for BAFF inhibition in systemic lupus erythematosusEffect of TACI signaling on humoral immunity and autoimmune diseasesA therapeutic role for BLyS antagonistsA soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeysAPRIL-deficient mice have normal immune system developmentFunctional implication of BAFF synthesis and release in gangliosides-stimulated microgliaBCMA is essential for the survival of long-lived bone marrow plasma cellsNormal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient miceCommon variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma riskToll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupusDeregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitorsTransmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.Autoimmunity in primary immune deficiency: taking lessons from our patients.Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors.APRIL mediates peritoneal B-1 cell homeostasis.Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.The expression of BAFF, APRIL and TWEAK is altered in eczema skin but not in the circulation of atopic and seborrheic eczema patientsRole of B cells in common variable immune deficiency.BLyS and APRIL in rheumatoid arthritis.Immune complex-mediated autoimmunity in a patient With Smith-Magenis syndrome (del 17p11.2).Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes.B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.Correlation of gene expression and genome mutation in single B-cells.The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.Innate control of B cell responses.The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiencyTACI deficiency enhances antibody avidity and clearance of an intestinal pathogenDifferential induction of plasma cells by isoforms of human TACI.Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and diseaseThe uncertain glory of APRIL.Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis.TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow.Altering immune tolerance therapeutically: the power of negative thinking.
P2860
Q24309087-AA151917-630D-4E86-A01D-CC7120503C5BQ24313032-02ABE6DA-CF2A-498A-B0FE-5EDEC111ECC1Q24628925-CD5AB79D-F064-4A83-9209-5A089B74A663Q24796930-D3D377D9-E788-4904-8C62-CC35ADC9C9ECQ26784444-3F6D61AD-17BA-40E0-813D-4B6A73847FBAQ26827373-B6876008-FE51-4C32-89A9-9AA0365B4468Q26995571-8B2AACDA-FCDB-4994-ABB5-C310A4E8E400Q28269809-EE747118-3443-43D4-9084-B5F5D8CF858AQ28293722-58594DDE-040B-4F89-A0CD-1139AB9F2761Q28511017-74A4ACF2-F1FF-4219-B495-50B1A3342CBEQ28581828-2BD6B33D-8DC9-4442-A0C7-ABFA637B843BQ28587037-EDE034D5-59C2-4F25-8FB8-CD5B04C6EF22Q28587370-A89132B1-8A4A-47EF-B831-BDB9B43998FEQ28943335-3A7EB81E-15A1-4DF5-A279-189C9D90BB37Q30425171-725791E7-512B-40FF-BC93-21C2AA32B9F0Q30426692-A2F81891-0B5E-4DA4-9A60-A967BEE205EEQ30436741-B8FF3A8E-AC73-4468-A81B-09D11953F2ACQ33377299-58B8781D-E7D7-4FE3-A2D6-876CD044FC6CQ33394794-033EC361-4F31-47D7-9299-F4971D50A2AFQ33429051-5804CA8E-5096-4131-A596-AD2BBFA8D4D1Q33521234-591F9B08-9B4A-4205-AB50-C3BBAE4E8EAFQ33758475-139CAE41-2163-4C90-84CE-5FBDAE4C729AQ33803763-7E628620-DAB3-42D3-BBC2-B0AE6ACDA27EQ33963947-8A122386-1086-4E58-8989-03C115524918Q34071102-97F0F2D6-4948-4A5F-8CEB-A84FCC1C4177Q34084521-5318917A-22A6-429E-A114-711F9582D025Q34359454-59F988CA-610F-4C67-BDE2-04776E77FECFQ34525054-867B55D9-35DF-44EC-87B4-03D95F42C2C6Q34781487-17921C5A-D7AE-45FC-9615-CD16B6291344Q34807778-40856065-6105-44B2-8214-119A27EB4D4FQ34810293-B97D5B04-7C36-4117-B2F5-9B330E899F44Q34958353-58C901FE-0D83-424B-BC04-EB172D4A9290Q35065333-B48E9086-DB2A-4FEA-A334-90180DA4F4F0Q35140137-3450FE49-4BE0-426D-ACC4-9E01E67CCA69Q35171263-1C2A0553-D6D5-4AA7-8BDF-1C543AA2B0EDQ35452032-A2A628EA-89DE-4F0F-9DD2-32C44C9A6A96Q35540065-AE95DD92-195E-4FA2-9717-F5516DF340E5Q35555539-4DE482BB-985B-4936-BAAB-0F6E42937579Q35585954-8E015BF4-CF10-45B4-857B-85593E7563BCQ35600811-2D6C8EE6-3907-4F9A-8B63-EB0385682A29
P2860
Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Loss of TACI causes fatal lymp ...... s an inhibitory BLyS receptor.
@ast
Loss of TACI causes fatal lymp ...... s an inhibitory BLyS receptor.
@en
Loss of TACI causes fatal lymp ...... s an inhibitory BLyS receptor.
@nl
type
label
Loss of TACI causes fatal lymp ...... s an inhibitory BLyS receptor.
@ast
Loss of TACI causes fatal lymp ...... s an inhibitory BLyS receptor.
@en
Loss of TACI causes fatal lymp ...... s an inhibitory BLyS receptor.
@nl
prefLabel
Loss of TACI causes fatal lymp ...... s an inhibitory BLyS receptor.
@ast
Loss of TACI causes fatal lymp ...... s an inhibitory BLyS receptor.
@en
Loss of TACI causes fatal lymp ...... s an inhibitory BLyS receptor.
@nl
P2093
P1433
P1476
Loss of TACI causes fatal lymp ...... s an inhibitory BLyS receptor.
@en
P2093
Daniel Tumas
Dhaya Seshasayee
Iqbal S Grewal
Minhong Yan
Patricia Valdez
Vishva M Dixit
P304
P356
10.1016/S1074-7613(03)00025-6
P407
P577
2003-02-01T00:00:00Z